BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37749112)

  • 1. Laterality influence on gene expression of DNA damage repair in colorectal cancer.
    Oliveira-Silveira J; Filippi-Chiela E; Saffi J
    Sci Rep; 2023 Sep; 13(1):15963. PubMed ID: 37749112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer.
    Huang W; Li W; Xu N; Li H; Zhang Z; Zhang X; He T; Yao J; Xu M; He Q; Guo L; Zhang S
    Cancer Med; 2023 May; 12(9):10187-10198. PubMed ID: 37096801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer.
    Arai H; Elliott A; Xiu J; Wang J; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Sohal D; Goldberg RM; Hall MJ; Scott AJ; Khushman M; Hwang JJ; Lou E; Weinberg BA; Marshall JL; Lockhart AC; Stafford P; Zhang J; Moretto R; Cremolini C; Korn WM; Lenz HJ
    Clin Cancer Res; 2021 Jun; 27(11):3234-3242. PubMed ID: 33766816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right-sided and left-sided colorectal cancer.
    Kanno H; Miyoshi H; Yoshida N; Sudo T; Nakashima K; Takeuchi M; Nomura Y; Seto M; Hisaka T; Tanaka H; Okuda K; Akagi Y; Ohshima K
    Cancer Sci; 2020 Aug; 111(8):3032-3044. PubMed ID: 32449240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-3607 inhibits the tumorigenesis of colorectal cancer by targeting DDI2 and regulating the DNA damage repair pathway.
    Lei L; Zhao X; Liu S; Cao Q; Yan B; Yang J
    Apoptosis; 2019 Aug; 24(7-8):662-672. PubMed ID: 31134446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sidedness of Colorectal Cancer Impacts Risk of Second Primary Gastrointestinal Malignancy.
    Broman KK; Bailey CE; Parikh AA
    Ann Surg Oncol; 2019 Jul; 26(7):2037-2043. PubMed ID: 30949861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
    Smolle MA; Kashofer K; Riedl JM; Stotz M; Gerger A
    Anticancer Res; 2019 Feb; 39(2):847-852. PubMed ID: 30711966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
    Song Y; Huang J; Liang D; Hu Y; Mao B; Li Q; Sun H; Yang Y; Zhang J; Zhang H; Chen H; Liu H; Zhang S
    Front Oncol; 2020; 10():549777. PubMed ID: 33680909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities.
    Silva P; Albuquerque C; Lage P; Fontes V; Fonseca R; Vitoriano I; Filipe B; Rodrigues P; Moita S; Ferreira S; Sousa R; Claro I; Nobre Leitão C; Chaves P; Dias Pereira A
    Int J Mol Med; 2016 Sep; 38(3):687-702. PubMed ID: 27430658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer.
    Al-Temaimi RA; Jacob S; Al-Ali W; Thomas DA; Al-Mulla F
    J Histochem Cytochem; 2013 Sep; 61(9):627-38. PubMed ID: 23797051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma.
    Wei M; Su J; Zhang J; Liu S; Ma J; Meng XP
    Front Oncol; 2023; 13():1043160. PubMed ID: 36816926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.
    Solier S; Zhang YW; Ballestrero A; Pommier Y; Zoppoli G
    Curr Cancer Drug Targets; 2012 May; 12(4):356-71. PubMed ID: 22385513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in DNA damage response inhibitors in colorectal cancer therapy.
    Yu Y; Jia H; Zhang T; Zhang W
    Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):15-22. PubMed ID: 38115743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study.
    Mochizuki K; Kudo SE; Ichimasa K; Kouyama Y; Matsudaira S; Takashina Y; Maeda Y; Ishigaki T; Nakamura H; Toyoshima N; Mori Y; Misawa M; Ogata N; Kudo T; Hayashi T; Wakamura K; Sawada N; Ishida F; Miyachi H
    Int J Colorectal Dis; 2020 Oct; 35(10):1911-1919. PubMed ID: 32548720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of radiation on levels of DNA damage in normal non-adjacent mucosa from colorectal cancer cases.
    Sheridan J; Tosetto M; Gorman J; O'Donoghue D; Sheahan K; Hyland J; Mulcahy H; Gibbons D; O'Sullivan J
    J Gastrointest Cancer; 2013 Mar; 44(1):41-5. PubMed ID: 23065707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.
    Slyskova J; Naccarati A; Pardini B; Polakova V; Vodickova L; Smerhovsky Z; Levy M; Lipska L; Liska V; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):225-32. PubMed ID: 22294771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Pattern of DAB Adaptor Protein 2 in Left- and Right-Side Colorectal Carcinoma.
    Šustić I; Racetin A; Vukojević K; Benzon B; Tonkić A; Šundov Ž; Puljiz M; Glavina Durdov M; Filipović N
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases.
    Sun J; Wang C; Zhang Y; Xu L; Fang W; Zhu Y; Zheng Y; Chen X; Xie X; Hu X; Hu W; Zheng J; Li P; Yu J; Mei Z; Cai X; Wang B; Hu Z; Shu Y; Shen H; Gu Y
    Nat Commun; 2019 Jul; 10(1):3190. PubMed ID: 31320627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Oxoguanine DNA Glycosylase 1 Upregulation as a Risk Factor for Obesity and Colorectal Cancer.
    Pilo J; García-Flores LA; Clemente-Postigo M; Arranz-Salas I; Alcaide J; Ramos-Fernandez M; Lozano J; Boughanem H; Kompella P; Macías-González M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
    Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
    Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.